CME icon

CME Group

248.87 USD
+0.55
0.22%
At close Feb 21, 4:00 PM EST
After hours
248.87
+0.00
0.00%
1 day
0.22%
5 days
0.06%
1 month
7.16%
3 months
9.85%
6 months
18.85%
Year to date
6.94%
1 year
15.75%
5 years
19.17%
10 years
162.00%
0
Funds holding %
of 7,139 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

149% more first-time investments, than exits

New positions opened: 177 | Existing positions closed: 71

53% more call options, than puts

Call options by funds: $491M | Put options by funds: $322M

38% more funds holding in top 10

Funds holding in top 10: 37 [Q3] → 51 (+14) [Q4]

20% more repeat investments, than reductions

Existing positions increased: 568 | Existing positions reduced: 472

3% more funds holding

Funds holding: 1,368 [Q3] → 1,413 (+45) [Q4]

5% more capital invested

Capital invested by funds: $70.6B [Q3] → $74B (+$3.4B) [Q4]

1.31% less ownership

Funds ownership: 88.91% [Q3] → 87.59% (-1.31%) [Q4]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$212
15%
downside
Avg. target
$255
3%
upside
High target
$269
8%
upside

8 analyst ratings

positive
25%
neutral
63%
negative
13%
Morgan Stanley
Mike Cyprys
57% 1-year accuracy
4 / 7 met price target
6%upside
$263
Equal-Weight
Maintained
19 Feb 2025
Keefe, Bruyette & Woods
Kyle Voigt
71% 1-year accuracy
22 / 31 met price target
3%upside
$257
Market Perform
Maintained
14 Feb 2025
RBC Capital
Ashish Sabadra
87% 1-year accuracy
47 / 54 met price target
8%upside
$269
Sector Perform
Maintained
13 Feb 2025
Oppenheimer
Owen Lau
72% 1-year accuracy
38 / 53 met price target
8%upside
$269
Outperform
Maintained
13 Feb 2025
JP Morgan
Kenneth Worthington
71% 1-year accuracy
24 / 34 met price target
15%downside
$212
Underweight
Maintained
13 Feb 2025

Financial journalist opinion

Based on 27 articles about CME published over the past 30 days

Positive
Zacks Investment Research
1 day ago
Has CME Group (CME) Outpaced Other Finance Stocks This Year?
Here is how CME Group (CME) and Main Street Capital (MAIN) have performed compared to their sector so far this year.
Has CME Group (CME) Outpaced Other Finance Stocks This Year?
Positive
Seeking Alpha
2 days ago
The Dividend Strategy That Could Make Me A Millionaire - And How You Can Copy It
Self-made millionaires build wealth through disciplined, consistent investing. I focus on dividend growth stocks, avoid single-stock risks, and live below my means to reinvest. I invest in wide-moat companies with strong fundamentals. Prioritizing dividend growth, I aim for income and long-term gains without timing the market. My picks reflect my conviction in dividend growth as a wealth-building tool. These stocks align with my long-term vision for financial security and success.
The Dividend Strategy That Could Make Me A Millionaire - And How You Can Copy It
Negative
24/7 Wall Street
3 days ago
Billionaire Owned Hedge Fund Dumps Uber And Buying These Stocks Instead
Forbes estimates Egerton Capital CIO John Armitage's net worth is $1.5 billion.
Billionaire Owned Hedge Fund Dumps Uber And Buying These Stocks Instead
Positive
Seeking Alpha
3 days ago
CME Group: High Quality With Good Dividend Yield
CME Group's near-monopoly in futures and options trading, with extraordinary 60% FCF margins, makes it a high-quality, capital-light business despite regulatory costs. Significant acquisitions like CBOT, NYMEX, and KCBT have solidified CME's market dominance, though future focus will be on dividends and smaller acquisitions. CME is slightly undervalued with a 4% dividend yield, making it a strong hold for dividend-focused investors seeking a high-quality business model.
CME Group: High Quality With Good Dividend Yield
Positive
Seeking Alpha
4 days ago
CME Group: A High-Quality Dividend Grower Available At Fair Value
CME Group has a dividend yield and a P/E ratio of 23.71, with a robust 10-year growth rate of 8%. The stock appears undervalued due to its strong balance sheet and market moat, presenting a potential buying opportunity. CME Group owns the world's largest derivatives exchanges, including CME, NYMEX, and COMEX, enhancing its market position.
CME Group: A High-Quality Dividend Grower Available At Fair Value
Positive
Seeking Alpha
6 days ago
Looking For Income? 2 High-Yield Dividend Stocks I'm Betting Big On
Inflation remains stubborn, and the Fed's "higher for longer" stance favors value stocks. I'm doubling down on high-yield plays with strong cash flow and earnings to thrive in this environment. My top picks are resilient, wide-moat businesses that excel in uncertainty. Both offer market-beating yields, growth potential, and inflation-resistant business models. While risks like rate cuts exist, these stocks are built to deliver steady income and long-term gains, making them core holdings in my portfolio.
Looking For Income? 2 High-Yield Dividend Stocks I'm Betting Big On
Neutral
CNBC Television
1 week ago
Final Trades: Toast, CME Group, Goldman Sachs and Diamondback Energy
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Toast, CME Group, Goldman Sachs and Diamondback Energy
Positive
Seeking Alpha
1 week ago
All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On
Thank you to the Seeking Alpha community for your support! Reaching 40,000 followers is a dream come true. Your feedback fuels my work. I've invested 91% of my net worth in 23 high-conviction dividend stocks. Focused on wide-moat businesses, I prioritize quality and long-term growth over yield. My portfolio has outperformed the S&P 500, and I'm confident in its future. I expect a rotation to value stocks, and I'll keep sharing insights to grow together.
All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On
Positive
Zacks Investment Research
1 week ago
CME Group Q4 Earnings and Revenues Beat Estimates, Rise Y/Y
CME's quarterly results benefit from improving revenues, driven by higher clearing and transaction fees as well as market data and information services fees.
CME Group Q4 Earnings and Revenues Beat Estimates, Rise Y/Y
Neutral
Seeking Alpha
1 week ago
CME Group Inc. (CME) Q4 2024 Earnings Call Transcript
CME Group Inc. (NASDAQ:CME ) Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ET Company Participants Adam Minick - Investor Relations Terry Duffy - Chairman & Chief Executive Officer Lynne Fitzpatrick - Chief Financial Officer Julie Winkler - Chief Commercial Officer Derek Sammann - Global Head, Commodities Suzanne Sprague - Chief Operating Officer & Head, Risk and Clearing Tim McCourt - Global Head, Equities, FX & Alternative Products Mike Dennis - Global Head, Fixed Income Conference Call Participants Patrick Moley - Piper Sandler Alex Kramm - UBS Michael Cyprys - Morgan Stanley Benjamin Budish - Barclays Capital Chris Allen - Citi Dan Fannon - Jefferies Brian Bedell - Deutsche Bank Bill Katz - TD Cowen Owen Lau - Oppenheimer Kyle Voigt - KBW Madeline Daleiden - JPMorgan Simon Clinch - Redburn Atlantic Operator Welcome to the CME Group Fourth Quarter 2024 Earnings Call. At this time, I would like to inform all participants that your lines have been placed on a listen-only mode until the question-and-answer session of today's conference.
CME Group Inc. (CME) Q4 2024 Earnings Call Transcript
Charts implemented using Lightweight Charts™